Journal of the Korean Chemical Society (대한화학회지)

Korean Chemical Society (대한화학회)
권호 표지

Synthesis of Dynorphin B Analogues by Solid-Phase Method

고상법에 의한 Dynorphin B 유도체의 합성

  • Published : 19980400
Download PDF
⟨ Previous Next ⟩

Abstract

Dynorphin B analogues, $[Arg^{11}, D-Ala^{12}]$dynorphin B, $[D-Ala^2, Ala^6, Arg^{11}, D-Ala^{12}]$dynorphin B, and dynorphin B (1-11) were synthesized by solid-phase method. A chloromethylated polystyrene resin cross-linked with 2% divinylbenzene was substituted with Thr in ethanol to contain 1.20 mmol Thr/g of resin. All amino groups of amino acids were protected with t-Boc group and 2,6-dichlorobenzyl and nitro groups were used to protect the side chains of Tyr and Arg, respectively. Stepwise synthetic method was applied for synthesis of the products. Dicyclohexylcarbodiimide (DCC) and 1-hydroxybenzotriazole (HOBT) were used as the coupling reagents. The crude peptides were purified by gel filteration on Sephadex LH-20 column $(2 \times 50 cm)$ using MeOH/MeCN (3/1) and then characterized with HPLC, amino acid analyzer.

Dynorphin B유도체들인 $[Arg^{11},\;D-Ala^{12}]$ dynorphin B, $[D-Ala^2,\;Ala^6,\;Arg^{11},\;D-Ala^{12}]$ dynorphin B 및 dynorphin B (1-11)를 고상법으로 합성하였다.에탄올 용액에서 2%의 디비닐벤젠으로 교차결합된 파라-염화메틸폴리스티렌 수지와 Thr을 반응시켜 수지 1g당 1.20 mmol의 Thr을 치환시켰다. 모든 아미노산의 아미노기는 t-Boc기로 보호하였으며 Tyr과Arg의 곁사슬은 2,6-디클로로벤질기와 니트로기로 각각 보호하였다. 각 유도체는 DCC와HOBT를 짝지음 시약으로 사용하여 단계적 합성법으로 합성하였으며 생성물은 MeOH/MeCN (3/1)을 전개용매로 하여 Sephadex LH-20 column (2${\times}$50 cm)으로 정제하였으며 HPLC와 아미노산 분석기로 확인하였다.

Keywords

References

  1. Nature. v.258 Hughs, J.;Smith, T. W.;Kosterlitz, H. V.;Fothergill
  2. Eur. J. Biochem. v.93 Kita, T.;Inoue, A.;Nakanishi, S.;Numa, S.
  3. Eur. J. Biochem. v.93 Taii, S.;Nakanishi, S.;Numa, S.
  4. Life, Sci. v.31 Kilpatrick, D. L.;Wahistrom, A.;Lanm, H. W.;Blacher, R.;Ezra, E.
  5. Proc. Natl. Acad. Sci. v.79 Goldstein, A.;Hunkapiler, M. W.;Hood, L. E.
  6. J. Pharmacol. Exp. Ther. v.228 James, I. F.;Fischli, W.;Goldstein, A.
  7. J. Neurosci. v.3 Cone, R. I.;Weber, E.;Barchas, J. D.;Goldstein, A.
  8. J. Pharmacol. Exp. Ther. v.222 Yoshimura, K.;Huidobro-toro, J. P.;Lee, N. M.;Loh, H. H.;Way, E. L.
  9. Life Sci. v.27 Eerman, B. H.;Leslie, F.;Goldstein, A.
  10. Eur. J. Pharmacol. v.68 Holtt, V.;Harrmann, I.;Seizinger, B.;Herz, A.
  11. Science. v.219 Przewlocki, R.;Lason, W.;Konecka, A. M.;Gramsch, C.;Herz, A.
  12. Biochem. Biophys. Res. Commun. v.103 no.2 Mattice, W. L.;Maroun, R.
  13. Biochem. Biophys. Res. Commun. v.101 no.4 Nattice, W. L.;Robinsor, R. M.
  14. Biochem. Biophys. Res. Commun. v.90 no.4 Conne, B. S.;Aubert, M. L.;Sixonenko, P. C.
  15. Proc. Natl. Acad. Sci. v.78 no.10 Goldstein, A.;Chavkin, C.
  16. J. Am. Chem. Soc. v.86 Merrifield, R. B.
  17. Principles of Peptide Synthesis Bodanszky, M.
  18. Ann. Chem. v.702 Schnabel, E.
  19. Helv. Chem. Acta. v.42 Schwyzer, R.;Sieber, P.;Kappeler, H.
  20. Solid Phase Peptide Synthesis(2nd Edition) Stewart, J. M.;Young, J. D.
  21. J. Am. Chem. Soc. v.95 Yamashiro, D.;Li, C. H.
  22. Helv. Chim. Acta. v.56 Gisin, B. F.